{"retracted":false,"update":{"timestamp":1476403200000,"doi":"10.1038/srep35509","type":"correction"},"doi":"10.1038/srep33825","journal":"Scientific Reports","publisher":"Springer Nature","title":"Erratum: Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment"}
